Can Vaccines Cause Cancer?
Some vaccines are cultured on neoplastic (aka cancerous) cell lines, which DO cause cancer in certain strains of mice. What’s even scarier is that the vaccines (ie Varivax, MMR) have NEVER BEEN TESTED FOR ABILITY TO CAUSE CANCER. You might want to ask yourself WHY have they never been tested? Is this a risk you really want for at most partial and/or temporary protection from childhood diseases such as: -chickenpox, which is admitted to be a benign illness even by the manufacturer of Varivax, or -measles, mumps and rubella, which have become rare diseases and are admitted by the CDC to rarely cause complications? I’M SURE SOME PHARMA SHILLS WILL LAY INTO ME FOR PUTTING THIS VIDEO UP, BUT FOR ANYONE READING THIS, PLEASE CHECK THE SOURCES YOURSELVES, EVERYTHING I SAY IN THIS VIDEO IS TRUE. HeLa cells, immortal cell lines, cell line contamination and cancer: curezone.com Information from FDA on immortal (neoplastic) cell lines, safety and testing www.fda.gov HeLa cells and contamination: arpa.allenpress.com While lab culturing may indicate that so called immortal cells are not immediately changing to overt tumor cells, it is now well known in the scientific community that after these cells have been repeatedly cultured a certain number of times, something causes them to convert to a cancerous state. Normal embryo cells presumably represent a state in development which is genetically unstable, rendering them considerably more susceptible to malignant transformation.[76] When …
Video Rating: 3 / 5
JVZoo Product Feed
Dr. confesses Cancer & other Viruses is found in Vaccines
Merck Vaccine Chief Brings HIV/AIDS to America AND THEY LAUGH ABOUT IT!! Wake Up and Americans Unite against the lies that is told to destroy our children. Here is an interview that is very rare and will shock you. Hear how the vaccinations were started what they have in it all from the mouth of Dr. Maurice Hillerman admitting to massive field trials, and hiding the truth from the press book mark this and show it to all your friends. Do not let them brainwash you into making your self sick seek out the truth about the natural healing powers of good OREGANO OIL that can kill viruses and the common cold. visit www.armchairsurvivalist.com Merck Vaccine Chief Brings HIV/AIDS to America This stunning censored interview conducted by medical historian Edward Shorter for WGBH public television (Boston) and Blackwell Science was cut from The Health Century due to its huge liability–the admission that Merck drug company vaccines have traditionally been injecting cancer viruses (SV40 and others) in people worldwide. This segment of In Lies We Trust: The CIA, Hollywood & Bioterrorism, produced and freely contributed by consumer protector and public health expert, Dr. Leonard Horowitz, features the world’s leading vaccine expert, Dr. Maurice Hilleman, who explains why Merck’s vaccines have spread AIDS, leukemia, and other horrific plagues worldwide. Please forward this clip (link) to everyone you know who thinks vaccines are “safe and effective.”
JVZoo Product Feed
A Poisoned World – Pt11 (intro link) – Deadly Military Vaccines
Click on this link to view video: vids.myspace.com Thousands of military personnel are being experimented upon like lab rats. many are dying because of these poisons and the US Government is turning their backs on them. Further proof of the New World Order Global Elitist depopulation agenda.
Video Rating: 5 / 5
Newest episode of ‘Biff and Ste Explore’, this time with added danger!…. and masks 
JVZoo Product Feed
Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical, 2011
Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical, 2011
Article by Bharatbook
Bharatbook added a new report on ” Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical, 2011 ” which gives an overview, Demand, Supply Trends and industry analysis reports.This report provides a comprehensive review of 27 candidate therapeutic antibodies and 42 candidate vaccines that are being evaluated for the treatment of covering pipeline, disease-targeting strategies and clinical findings. These antibodies are directed at 17 targets, while the vaccines are directed at 24 antigens or antigen combinations.
Globally, the most common cancer and in 2008 there were an estimated 1.6 million new cases and 1.4 million deaths (almost 20% of all cancer deaths) caused by this disease. Five-year survival rates are also low (15-20%) compared to other common cancers. In the US, studies have shown that lung cancer-care costs (in 2006) were the third highest of all cancers, while indirect costs (2005) were higher than for any other cancer.
Patient needs and the high burden of are driving the development of new therapies. While improvements have been seen in diagnosis and treatments (surgery, radiotherapy, chemotherapy and targeted drugs), new therapies that build on the capabilities of existing strategies, are urgently required. Today, advances continue to be made in drug treatments for chemotherapy, new drug combinations and targeted molecules. In particular, advances are being seen in the field of immunotherapy, in the development of new therapeutic antibodies and therapeutic vaccines.
This Report
This report provides a comprehensive review of lung cancer immunotherapy. With a focus on therapeutic vaccines and antibodies, it reviews R&D and clinical developments in the treatment of as the primary indication, as well as studies that are evaluating lung cancer alongside other cancers. It provides a comprehensive review of pipeline developments, therapeutic strategies and clinical findings, covering therapeutic vaccines and antibodies.
Today, around 70 immunotherapies are being developed or evaluated for the treatment of lung cancer. This report reviews developments on 27 candidate therapeutic antibodies and 42 candidate vaccines for treating most of which are in clinical development.
The immunotherapy pipeline is showing substantial innovation and many new strategies are being evaluated. Today’s pipeline of therapeutic antibodies are directed at 17 drug targets. On the vaccine front, 24 different antigen/multiple antigen targeting strategies are being investigated. For the purpose of this report, multiple antigen targeting vaccines have been treated as single targeting strategies.
More than 90% of the immunotherapy candidates in development or being evaluated for treating are identified in this report, are in clinical development. This report gives an overview of the status and clinical findings of these candidate therapies. It also gives developmental and market-related perspectives in this rapidly developing field.
Key content:
• Late-stage (Phases 2/3, 3 and Approved, n = 4) therapeutic antibodies and companies• Early-stage (Preclinical and Phases 1, 1/2 and 2, n= 23) therapeutic antibodies and companies• Late-stage (Phases 2/3, 3 and Approved, n = 5) vaccines and companies• Early-stage (Preclinical and Phases 1, 1/2 and 2, n= 37) vaccines and companies• Other (mainly antibody related, n=6) candidate therapies in the development pipeline for targeting hases 1, 1/2 and 2• Drug targets against which therapeutic antibodies are being directed, from preclinical through to Phase 3, and Approved• Antigen/antigen combinations being targeted by vaccines, from preclinical through to Phase 3, and Approved• Descriptions of clinical trials (patients and numbers, conditions, treatments, regimens, Phases 1-3) of therapeutic antibodies and vaccines being evaluated for the treatment of lung cancer• Summaries of the clinical status and clinical findings (safety, adverse events and multiple event-related clinical responses), following clinical trials (Phases 1-3) of therapeutic antibodies being evaluated for the treatment of lung cancer• Summaries of the clinical status and clinical findings (safety, adverse events and multiple event-related clinical responses), following clinical trials (Phases 1-3) of vaccines being evaluated for the treatment of lung cancer• Commercial partnerships and collaborations on pipeline therapeutic antibodies and vaccines• Drug combination strategies in the evaluation of therapeutic antibodies and vaccines for targeting• A comprehensive listing of salient details of clinical trials of therapeutic antibodies and vaccines being evaluated for the treatment of lung cancer• Technical and market insights and perspectives in the development and clinical evaluation of therapeutic antibodies and vaccines for the treatment of lung cancer• Competitive and market-related information
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=213740&rt=Lung-Cancer-Vaccines-and-Therapeutic-Antibodies-Pipeline-Strategies-and-Clinical-2011.html
Or
Contact us at :
Bharat Book BureauTel: +91 22 27578668 / +91 22 27579438Fax: +91 22 27579131Email: info@bharatbook.comWebsite: http://www.bharatbook.com
About the Author
Bharat Book Bureau, the leading market research information aggregator provides company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.
Find More Survival Rate Lung Cancer Articles
JVZoo Product Feed
Categories: Articles Tags: strategies, antibodies, clinical, lung, therapeutic, cancer, pipeline, 2011 , vaccines
Lung Cancer Vaccines: Pipeline, Strategies and Clinical
Lung Cancer Vaccines: Pipeline, Strategies and Clinical
Article by Bharatbook
Bharatbook added a new report on ” Lung Cancer Vaccines: Pipeline, Strategies and Clinical ” which gives an overview, Demand, Supply Trends and industry analysis reports.This report provides a comprehensive review of 42 candidate vaccines that are being evaluated for the treatment of covering pipeline, disease-targeting strategies and clinical findings. These vaccines are directed at 24 antigens or antigen combinations.
Globally, the most common cancer and in 2008 there were an estimated 1.6 million new cases and 1.4 million deaths (almost 20% of all cancer deaths) caused by this disease. Five-year survival rates are also low (15-20%) compared to other common cancers. In the US, studies have shown that lung cancer-care costs (in 2006) were the third highest of all cancers, while indirect costs (2005) were higher than for any other cancer.
Patient needs and the high burden of drive the development of new therapies. While improvements have been seen in diagnosis and treatments (surgery, radiotherapy, chemotherapy and targeted drugs), new therapies that build on the capabilities of existing approaches, are urgently required. Today, developments continue to be made in drug treatments for in chemotherapy, new drug combinations and targeted molecules. In particular, advances are being seen in the field of immunotherapy; in the development of new therapeutic antibodies and therapeutic vaccines.
This Report
This report (see brochure) provides a comprehensive review of vaccines and reviews R&D and clinical developments in the treatment of as the primary indication, as well as studies that are evaluating alongside other cancers.
Today, more than 40 candidate vaccines are in development or being evaluated for the treatment of most of which are already in clinical trials. This field is also showing substantial innovation and 24 different antigen/multiple antigen targeting strategies are being investigated. For the purpose of this report, multiple antigen targeting approaches have been treated as single strategies. This report gives an overview of the status and clinical findings of these candidate vaccines, and gives developmental and market-related perspectives in this rapidly developing field.
Key content:
• Late-stage (Phases 2/3, 3 and Approved, n = 5) pipeline vaccines and companies• Early-stage (Preclinical and Phases 1, 1/2 and 2, n= 37) pipeline vaccines and companies• Other (mainly antibody related, n=6) candidate therapies in the development pipeline for targeting Phase 1, 1/2 and 2• Antigens/antigen combinations being targeted by vaccines from preclinical through to Phase 3 and Approved• Descriptions of clinical trials (patients and numbers, conditions, treatments, regimens, Phase 1-3) of therapeutic vaccines being evaluated for the treatment. • Summaries of clinical status and clinical findings (safety, adverse events and multiple event-related clinical responses) reported following clinical trials (Phase 1-3) of vaccines being evaluated for the treatment of lung cancer• Commercial partnerships and collaborations on pipeline therapeutic vaccines• Drug combination strategies in the evaluation of therapeutic vaccines for the targeting.• A comprehensive listing of salient details of clinical trials of therapeutic vaccines being evaluated for the treatment.• Technical and market insights and perspectives in the development and clinical evaluation of therapeutic vaccines for the treatment.• Competitive and market-related information
Tables
Global incidence and mortality from 2008NSCLC survival rates, according to cancer stage1.3a Five-year relative cancer survival rates in the USA for white males1.3b Five-year relative cancer survival rates in the USA for white femalesUS national expenditure on different cancers (2006)US lost productivity due to different cancer types in the US, 20052.1 Approved/late-stage vaccines for the treatment of lung cancer3.1 Early-stage vaccines being developed or evaluated for the treatment of lung cancer/other cancers4.1 Other (largely antibody-related) therapies being developed or evaluated for the treatment of other cancers5.1 Approved/late-stage candidate vaccines being developed for the treatment of lung cancer5.2 Early-stage candidate vaccines being developed or evaluated for lung/other cancersOther (primarily antibody-related) therapies in development or being evaluated for lung cancer/other cancersApproved/candidate vaccines for the treatment of for other cancersOther candidate therapies (primarily antibody-related) for the treatment of for other cancersNSCLC survival rates, according to cancer stage
Figures
3.1 Early-staged pipeline vaccines for the treatment of lung cancer or other cancers5.1 Early-stage pipeline vaccines in development or being evaluated for lung/other cancers5.2 Other (primarily antibody-related) early-stage candidate therapies in development or being evaluated for other cancers5.3 Organisations developing or evaluating lung cancer therapeutic vaccines5.4 Clinical trials of vaccines for the treatment of other cancers, involving single or combination agents
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=213743&rt=Lung-Cancer-Vaccines-Pipeline-Strategies-and-Clinical.html
Or
Contact us at :
Bharat Book BureauTel: +91 22 27578668 / +91 22 27579438Fax: +91 22 27579131Email: info@bharatbook.comWebsite: http://www.bharatbook.com
About the Author
Bharat Book Bureau, the leading market research information aggregator provides company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.
JVZoo Product Feed
HPV Vaccines
Human papillomavirus is a common sexually transmitted infection–more than half of sexually active men and women are infected with HPV at some time in their lives. But HPV vaccines can help prevent infection from both high risk HPV types that can lead to cervical cancer and low risk types that cause genital warts. HPV vaccines are recommended for girls ages 11-12. Catch up vaccination is recommended for girls and young women ages 13-26 who have not been previously vaccinated. Males are also at risk for a number of HPV diseases, so boys and young men ages 9-26 can also be vaccinated against HPV.
JVZoo Product Feed
Autism (and other diseases such as SIDS) link to Vaccines?
Question by Chickadee!: Autism (and other diseases such as SIDS) link to Vaccines?
Disprove me! I dare you! Tell me that I’m crazy, that I just don’t want to blame my parents for what happened to my brother, that I just want to have something to blame!
I don’t want vaccines to be the cause of autism…I would love it if it weren’t…if I knew the pharmaceutical companies weren’t doing this to one in one hundred and fiftey children!
But I’ve done my research. I have done so much research. Research you wouldn’t think possible for a fourteen year old girl. And I have come to this conclusion…it makes sense…and I believe it.
I’d like to give part of my argument.
1. Chelation therapy that removesheavy metals from the system has been proven affective for treating autism
2. Vaccine rates correspond with autism rates
3. The symptoms of mercury poisoning and autism are identical…autism is a list of symptoms.
4. There was a low rate of autism in other countries until we sent our vaccines, and it skyrocketed.
Now before you start, I’d like to tell you something…
Fifty years ago, health officials siad it was okay to smoke…said it didn’t cause lung cancer….told pregnant women to smoke, said it calmed their nerves…and now you can’t go anywhere without seeing a sign warning you of the dangers of smoking….I hope one day soon, we look back on autism and mercury and all those other disease like that.
(Refrigerator mothers was stupid in the first place and has been ruled out! Old dads is not an option…My father was 31 when my mother gave birth to my brother with autism)
Note : You can bad mouth me….Whatever….But don’t bad mouth my brother or my parents! That Family Guy Show recently that made fun of Sarah Palin….didn’t really make fun of Sarah Palin…it was making fun of special needs kids…and it made me mad….not only does Sarah Palin deserve and apology….so many more people do…my brother does…some of my friends do….so many people in our world deserve and apology for what was brodcasted on Family Guy….Thank you.
(nvic.org….Dr.Boyd Haley….individual research)
Best answer:
Answer by poprocks_and_coke
Wow you really have done your research. I love that you not only mention autism but also SIDS. So many people try to argue that not getting vaccinated isn’t worth it because autism is better than having your child die from one of the diseases we get vaccinated for but I never see anyone mention that its believed theirs a connection between vaccines and SIDS. And your absolutely right about the chelation therapy, to me that is the biggest PROOF that people seem to ignore.
If you want to get more responses post this in the newborn and baby section, there are so many moms in there that love to argue about this topic and claim that vaccines don’t cause autism because all of their kids were vaccinated and don’t have it (I love that argument, its like me saying smoking doesn’t cause cancer because I smoke and don’t have cancer). I’d love to see what arguments they can come up with to dispute what you have wrote.
Know better? Leave your own answer in the comments!
JVZoo Product Feed
Promising Immunotherapy Cancer Vaccines for Lung Cancer
Dr. Charles Butt’s discusses emerging cancer vaccines in late stage clinical development that could potentially change the course of how we treat cancer.
Video Rating: 5 / 5
Read More : reallyabovetopsecret.com
Video Rating: 0 / 5
JVZoo Product Feed
What are the major vaccines treatments, or therapies for lung cancer?
Question by A: What are the major vaccines treatments, or therapies for lung cancer?
I need to know the major treatments for lung cancer, thanks a lot,
Please no wikipedia.com, just need to know the treatments thank you
And also worldwide accessibility, as in who can get the treatment, and how much does it generally cost? NO wikipedia.org please.
Best answer:
Answer by Carol
Hello A:
I know what I am on. I take dextrosmethazone 2 X a day as well as
a nubulizer treatment 2 X a day with more steroids and they were doing
radiation on top of that
They already took my left lung. So I only have one.
I hope this information will help.
Give your answer to this question below!
JVZoo Product Feed
Categories: Answers Tags: lung, treatments, major vaccines, vaccines, major, therapies, cancer, wikipedia how much it cost to get treatment for lung cancer
Merck Dr. ADMITS Cancer & Other Viruses Found In Vaccines
Merck Vaccine Chief Brings HIV/AIDS to America AND THEY LAUGH ABOUT IT!! Wake Up and Americans Unite against the lies that is told to destroy our children. Here is an interview that is very rare and will shock you. Hear how the vaccinations were started what they have in it all from the mouth of Dr. Maurice Hillerman admitting to massive field trials, and hiding the truth from the press book mark this and show it to all your friends. Do not let them brainwash you into making your self sick seek out the truth about the natural healing powers of good OREGANO OIL that can kill viruses and the common cold. visit www.armchairsurvivalist.com Merck Vaccine Chief Brings HIV/AIDS to America This stunning censored interview conducted by medical historian Edward Shorter for WGBH public television (Boston) and Blackwell Science was cut from The Health Century due to its huge liability–the admission that Merck drug company vaccines have traditionally been injecting cancer viruses (SV40 and others) in people worldwide. This segment of In Lies We Trust: The CIA, Hollywood & Bioterrorism, produced and freely contributed by consumer protector and public health expert, Dr. Leonard Horowitz, features the world’s leading vaccine expert, Dr. Maurice Hilleman, who explains why Merck’s vaccines have spread AIDS, leukemia, and other horrific plagues worldwide. Please forward this clip (link) to everyone you know who thinks vaccines are “safe and effective.”
Video Rating: 4 / 5
JVZoo Product Feed
